Treating Obesity is Disease-Modifying (9.4.2026)

Save

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. New drugs approved, new drugs halted and some drugs out of control.

A Day in the Life of a Rheumatology APP: A Focus on Interstitial Lung Disease” (hosted by Amanda Mixon, PA-C)

Save

Join Amanda Mixon, PA-C, for a practical look at the role of the rheumatology advanced practice provider (APP) in recognizing and managing interstitial lung disease (ILD). Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

DERM on RheumNow PODCAST (August 2026)

Save

The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, CTD skin disorders. dermatology drugs, biologics, andJAK inhibitors - their use, efficacy and side effects. Features Dr.

NME: New Molecular Entities (8.28.2026)

Save

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Label update: Structural damage progression in active PsA

Save

Listen to Dr. Catherine Bakewell’s review of clinical data from a recent label update. Sponsored by Johnson & Johnson Medical Affairs

Rheum Scholarship (8.21.2026)

Save

Dr. Cush reviews the news and journal articles from this past week on RheumNow.com; talking about lumbar belts, scholarships and misdiagnosis.

Doubting RS3PE (8.14.2026)

Save

Dr. Jack Cush reviews the news and journal articles this week where RheumNow featured info on cancer, deadly viruses, AI rules, poetry and good moons rising.

Mentshlichkeit (8.7.2026)

Save

Dr. Jack Cush reviews the news and recent journal reports on RheumNow.com

A JAKi After TNFi Failure in RA: SELECT-SWITCH at Week 12

Save

Dr. Christina Charles-Schoeman and Dr. Manish Jain are back to discuss treatment considerations after TNFi failure in RA. Join them as they review the latest data from SELECT-SWITCH, including post hoc results in primary and secondary nonresponders presented at EULAR 2026. Learn how those findings impact their clinical decision-making. Sponsored by AbbVie Medical Affairs + Health Impact

TU: Systemic Burden of Gout Part 2 (24 plus)

Save

Dr. Jack Cush Obesity & Gout Dr. Tony Merriman Genome-Wide Association Studies in Gout Dr. Lisa Stamp Gout Management in Patients with Chronic Kidney Disease Dr. Mark Fisher Gout & Mortality

Methotrexate Safety Tips (7.31.2026)

Save

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Gout Lessons from the Clinic Part 3

Save

Dr. Sheila Reyes: QD Clinic: The Highs and Lows of a Woman with Gout Dr. Jack Cush QD319 A Watched Tophus Never Resolves Dr. Eric Dein QD316: Addressing Severe Gout Flares Dr. Janet Pope QD Clinic: RA Mimics — Two Cases That Turned Out to Be Gout

DERM on RheumNow (July 2026)

Save

The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, CTD skin disorders. dermatology drugs, biologics, andJAK inhibitors - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: - 20 yr. Tx trends in 6583 #SSc pts. 2005 to 2025 endothelin receptor antagonists & prostanoids/prostacyclins from 3% to 28%.

New, Advanced Therapies in Gout

Save

New, Advanced Therapies in Gout explores the rapidly evolving therapeutic landscape beyond conventional urate-lowering therapy.

Systemic Burden of Gout Part 1

Save

Dr. Robert Terkeltaub 3 New Things it Pays to Know About Gout Pathobiology Dr. Nicola Dalbeth Outcomes of Tophaceous Gout Dr. Ted Mikuls Subclinical Inflammation in Intercritical Gout Dr. Michael Pillinger Gout and Cardiovascular Disease: What's the Risk? What's the Connection?